PROCEPT BioRobotics shares are trading higher after Leerink Partners initiated coverage on the stock with an Outperform rating and $37 price target.
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners has initiated coverage on PROCEPT BioRobotics with an Outperform rating and a price target of $37. This has led to an increase in the trading of PROCEPT BioRobotics shares.
October 16, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
PROCEPT BioRobotics' stock is trading higher following Leerink Partners' Outperform rating and $37 price target.
The Outperform rating and $37 price target set by Leerink Partners indicates a positive outlook for PROCEPT BioRobotics. This has led to increased trading of the company's shares, suggesting a potential short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100